Frontiers | Manipulation of the diet–microbiota–brain axis in Alzheimer's disease
Fc effector of anti-Aβ antibody induces synapse loss and cognitive deficits in Alzheimer's disease-like mouse model | Signal Transduction and Targeted Therapy
Amyloid blood biomarker detects Alzheimer's disease | EMBO Molecular Medicine
Biomolecules | Free Full-Text | Microvascular Contributions to Alzheimer Disease Pathogenesis: Is Alzheimer Disease Primarily an Endotheliopathy?
Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer's Disease Therapeutics
Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline | Alzheimer's Research & Therapy | Full Text
Mechanisms of action of anti-Aβ-antibodies. Anti-Aβ-antibodies can... | Download Scientific Diagram
SARS-CoV-2 infection increases the gene expression profile for Alzheimer's disease risk: Molecular Therapy - Methods & Clinical Development
IJMS | Free Full-Text | CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
Structural Dynamics of Amyloid-β Protofibrils and Actions of Anti-Amyloid-β Antibodies as Observed by High-Speed Atomic Force Microscopy | Nano Letters
Amyloid-β (Aβ) marker expression and Aβ aggregation in the... | Download Scientific Diagram
Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre‐clinical AD, amnestic mild cognitive impairment and late‐stage AD - Tramutola - 2015 -
Decreased salivary lactoferrin levels are specific to Alzheimer's disease - eBioMedicine
Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review - ScienceDirect
Frontiers | Alzheimer's disease: a mini-review for the clinician
Identifying and validating biomarkers for Alzheimer's disease: Trends in Biotechnology
ADPD 2023: Alzheimer's Disease Therapeutics, Diagnostics & Mechanisms
Blood‐based biomarkers for Alzheimer's disease | EMBO Molecular Medicine
JPM | Free Full-Text | Current Biomarkers for Alzheimer's Disease: From CSF to Blood
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease - eBioMedicine
Biomedicines | Free Full-Text | Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers
Synergistic Association between Plasma Aβ1–42 and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia | ACS Chemical Neuroscience
Advances in the development of new biomarkers for Alzheimer's disease | Translational Neurodegeneration | Full Text
Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer's Disease | ACS Omega
Association of B cell profile and receptor repertoire with the progression of Alzheimer's disease - ScienceDirect
Amyloid‐β oligomers in cellular models of Alzheimer's disease - Fontana - 2020 - Journal of Neurochemistry - Wiley Online Library
Cells | Free Full-Text | Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
